Trade-Ideas: China Biologic Products (CBPO) Is Today's Strong And Under The Radar Stock

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified China Biologic Products ( CBPO) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified China Biologic Products as such a stock due to the following factors:

  • CBPO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $11.7 million.
  • CBPO is making at least a new 3-day high.
  • CBPO has a PE ratio of 39.
  • CBPO is mentioned 1.81 times per day on StockTwits.
  • CBPO has not yet been mentioned on StockTwits today.
  • CBPO is currently in the upper 20% of its 1-year range.
  • CBPO is in the upper 35% of its 20-day range.
  • CBPO is in the upper 45% of its 5-day range.
  • CBPO is currently trading above yesterday's high.

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

If you liked this article you might like

Chinese Plasma Maker China Biologic a Solid Addition for a Portfolio

Today's Perilous Reversal Stock: China Biologic Products (CBPO)

Strong On High Relative Volume: China Biologic Products (CBPO)

Insider Trading Alert - UUUU, ZAYO And CBPO Traded By Insiders

China Biologic Products (CBPO) Highlighted as Today's Perilous Reversal Stock